rsv tube
Georgia State Spinoff Receives $225,000 To Develop Safe, Effective RSV Vaccine
Published July 17, 2018 in News Hub
Advac, LLC, a vaccine research company founded by Sang-Moo Kang, a professor in the Institute for Biomedical Sciences at Georgia State University, has received $225,000 from the National Institutes of Health to develop a safer, more effective vaccine for human respiratory syncytial virus (RSV).
Georgia State Researcher Gets $419,100 Grant To Study Virus Similar To Ebola
Published July 12, 2018 in News Hub
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Georgia State Receives $1.4 Million To Study Effects Of E-cigarette Regulations
Published July 11, 2018 in News Hub
Georgia State University has received $1.4 million from the National Institutes of Health to lead a four-year research initiative that will evaluate the effects of early attempts to regulate electronic cigarettes (e-cigarettes).

Featured Researchers

Research News

rsv tube
Georgia State Spinoff Receives $225,000 To Develop Safe, Effective RSV Vaccine
Published July 17, 2018 in News Hub
Advac, LLC, a vaccine research company founded by Sang-Moo Kang, a professor in the Institute for Biomedical Sciences at Georgia State University, has received $225,000 from the National Institutes of Health to develop a safer, more effective vaccine for human respiratory syncytial virus (RSV).
Georgia State Researcher Gets $419,100 Grant To Study Virus Similar To Ebola
Published July 12, 2018 in News Hub
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Georgia State Receives $1.4 Million To Study Effects Of E-cigarette Regulations
Published July 11, 2018 in News Hub
Georgia State University has received $1.4 million from the National Institutes of Health to lead a four-year research initiative that will evaluate the effects of early attempts to regulate electronic cigarettes (e-cigarettes).

Featured Researchers